Trial Details

RECRUITING
Basic Information
Clinical ID c121
Identifier NCT06780683
Trial Title Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease|Crohn's Disease|Ulcerative Colitis
Interventions DRUG: Upadacitinib
Participant Information
Sponsor Xiang Gao
City Guangzhou
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2024-01-01
Primary Completion Date 2028-12-31
Completion Date 2028-12-31